Proton and Intensity-Modulated Radiation Therapy for Oropharyngeal Cancer Show Similar Late Effects, QoL, Gastrostomy Dependence, Swallow Function, Local Control and OS By Ogkologos - April 2, 2026 37 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the TORPEdO study Source RELATED ARTICLESMORE FROM AUTHOR Clinical Activity of Elraglusib with Gemcitabine Plus Nab-paclitaxel in First-Line Treatment of Patients with Metastatic Pancreatic Ductal Adenocarcinoma EMA Recommends Granting a Conditional Marketing Authorisation for Nadofaragene Firadenovec Pembrolizumab Plus Weekly Paclitaxel, With Or Without Bevacizumab, Improves OS in Patients With Platinum-Resistant Recurrent Ovarian Cancer MOST POPULAR How My Stage 4 Esophageal Cancer Diagnosis Led Me to a... January 12, 2023 Treatment with Tebentafusp Results in Longer Overall Survival Among Previously Untreated... September 27, 2021 12 myths about sun safety debunked July 31, 2023 Binimetinib Contributes to the Efficacy and Safety Outcomes Observed with Encorafenib... September 4, 2023 Load more HOT NEWS New on NCI’s Websites for June 2022 To Treat Pancreatic Cancer, Mouse Study Suggests Altering Tumor Microbiome New on NCI’s Websites for January 2020 Efficacy of Sunitinib in Patients with Metastatic Phaeochromocytomas and Paragangliomas
